ZPL-5212372
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZPL-5212372, covering 2019-04-05 to 2019-04-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis [Phase 1, Phase 2]